Kolmar BNH Co., Ltd. (200130.KQ)
KRW 13230.0
(0.53%)
KRW 13230.0
(0.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 208.12 Billion KRW | 35.65% |
| 2022 | 153.42 Billion KRW | 120.48% |
| 2021 | 69.58 Billion KRW | 67.54% |
| 2020 | 41.53 Billion KRW | 70.29% |
| 2019 | 24.39 Billion KRW | 165.26% |
| 2018 | 9.19 Billion KRW | -35.36% |
| 2017 | 14.22 Billion KRW | 103.59% |
| 2016 | 6.98 Billion KRW | 1064.5% |
| 2015 | 600 Million KRW | 0.0% |
| 2014 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 230.13 Billion KRW | 1.31% |
| 2024 Q1 | 227.16 Billion KRW | 9.15% |
| 2023 Q4 | 208.12 Billion KRW | 3.8% |
| 2023 Q1 | 183.32 Billion KRW | 19.49% |
| 2023 Q3 | 200.5 Billion KRW | 1.9% |
| 2023 FY | 208.12 Billion KRW | 35.65% |
| 2023 Q2 | 196.75 Billion KRW | 7.33% |
| 2022 FY | 153.42 Billion KRW | 120.48% |
| 2022 Q4 | 153.42 Billion KRW | 26.62% |
| 2022 Q3 | 121.17 Billion KRW | 22.13% |
| 2022 Q1 | 80.12 Billion KRW | 15.14% |
| 2022 Q2 | 99.21 Billion KRW | 23.83% |
| 2021 FY | 69.58 Billion KRW | 67.54% |
| 2021 Q1 | 50.67 Billion KRW | 27.1% |
| 2021 Q2 | 58.03 Billion KRW | 14.51% |
| 2021 Q4 | 69.58 Billion KRW | 10.68% |
| 2021 Q3 | 62.87 Billion KRW | 8.34% |
| 2020 Q1 | 28.91 Billion KRW | 25.51% |
| 2020 Q3 | 32.05 Billion KRW | -0.02% |
| 2020 Q4 | 39.87 Billion KRW | 24.4% |
| 2020 FY | 41.53 Billion KRW | 70.29% |
| 2020 Q2 | 32.05 Billion KRW | 10.89% |
| 2019 Q1 | 9.51 Billion KRW | 3.47% |
| 2019 FY | 24.39 Billion KRW | 165.26% |
| 2019 Q3 | 17.57 Billion KRW | 62.99% |
| 2019 Q2 | 10.78 Billion KRW | 13.36% |
| 2019 Q4 | 23.03 Billion KRW | 31.05% |
| 2018 FY | 9.19 Billion KRW | -35.36% |
| 2018 Q1 | 12.97 Billion KRW | -8.77% |
| 2018 Q2 | 11.58 Billion KRW | -10.74% |
| 2018 Q3 | 9.88 Billion KRW | -14.63% |
| 2018 Q4 | 9.19 Billion KRW | -7.02% |
| 2017 Q3 | 14.86 Billion KRW | -0.19% |
| 2017 Q1 | 7.84 Billion KRW | 12.21% |
| 2017 FY | 14.22 Billion KRW | 103.59% |
| 2017 Q2 | 14.89 Billion KRW | 89.98% |
| 2017 Q4 | 14.22 Billion KRW | -4.31% |
| 2016 Q2 | 4.6 Billion KRW | 666.67% |
| 2016 Q4 | 6.98 Billion KRW | 15.11% |
| 2016 Q3 | 6.07 Billion KRW | 31.96% |
| 2016 Q1 | 600 Million KRW | 0.0% |
| 2016 FY | 6.98 Billion KRW | 1064.5% |
| 2015 Q2 | 2.04 Billion KRW | 6.94% |
| 2015 Q3 | 600 Million KRW | -70.71% |
| 2015 Q4 | 600 Million KRW | 0.0% |
| 2015 FY | 600 Million KRW | 0.0% |
| 2015 Q1 | 1.91 Billion KRW | 0.0% |
| 2014 FY | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeoPharm CO., LTD. | 1.04 Billion KRW | -19766.216% |